Comparison

(R)-Pirtobrutinib

Item no. DCC-DC46686-100mg
Manufacturer DCChemicals
CASRN 2101700-14-3
Amount 100 mg
Category
Type Inhibitors
Specific against other
Purity >98%
Smiles FC([C@@]([H])(C([H])([H])[H])N1C(=C(C(N([H])[H])=O)C(C2C([H])=C([H])C(C([H])([H])N([H])C(C3C([H])=C(C([H])=C([H])C=3OC([H])([H])[H])F)=O)=C([H])C=2[H])=N1)N([H])[H])(F)F
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Manufacturer - Applications
(R)-Pirtobrutinib ((R)-LOXO-305) is a less active enantiomer of Pirtobrutinib. Pirtobrutinib (LOXO-305), a highly selective and non-covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations.
Molecular Weight
479, 4275

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close